Ignyta Press Releases

Date Title Download
Sep 23, 2016 Ignyta to Present at the Ladenburg Thalmann 2016 Healthcare Conference
SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a presentation at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September 27, 2016,
flame-pdf-icon
Sep 23, 2016 Ignyta to Present at the Ladenburg Thalmann 2016 Healthcare Conference
SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a presentation at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September 27, 2016,
flame-pdf-icon
Sep 23, 2016 Ignyta to Present at the Ladenburg Thalmann 2016 Healthcare Conference
SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a presentation at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September 27, 2016,
flame-pdf-icon